Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement

Sayuri Yamabe1, Yoshihiro Dohi2, Akifumi Higashi1

  • 1Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-0037, Japan.

Heart and Vessels
|November 5, 2015
PubMed

Insights

Regression of electrocardiographic left ventricular hypertrophy (ECG-LVH) after aortic valve replacement (AVR) indicates reverse remodeling. Sokolow-Lyon voltage decrease after AVR reflects reduced left ventricular mass and dimensions, serving as a marker for successful treatment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Cardiac Surgery

Background:

  • Severe aortic stenosis often leads to electrocardiographic left ventricular hypertrophy (ECG-LVH).
  • Aortic valve replacement (AVR) is a standard treatment for severe aortic stenosis.
  • The Sokolow-Lyon voltage criterion (SV1 + RV5/6) is widely used to diagnose ECG-LVH.

Purpose of the Study:

  • To investigate if the regression of Sokolow-Lyon voltage after AVR correlates with echocardiographic evidence of left ventricular reverse remodeling.
  • To identify echocardiographic predictors of ECG-LVH regression following AVR.

Main Methods:

  • A cohort of 129 patients with severe aortic stenosis undergoing AVR was analyzed.
  • 38 patients with preoperative ECG-LVH (SV1 + RV5/6 ≥ 3.5 mV) were included.
  • Electrocardiography and echocardiography were performed pre- and 1-year post-AVR.

Main Results:

  • ECG-LVH regression was observed in 19 patients.
  • The ECG-LVH regression group showed significantly greater reductions in left ventricular mass index and dimensions compared to the non-regression group.
  • Independent predictors of ECG-LVH regression included decreased left ventricular mass index, end-diastolic dimension, and end-systolic dimension.

Conclusions:

  • Regression of ECG-LVH after AVR is associated with significant left ventricular reverse remodeling.
  • Sokolow-Lyon voltage regression serves as a valuable non-invasive marker for assessing the impact of AVR on left ventricular structure.
  • ECG-LVH regression provides an estimation of the extent of reverse remodeling achieved post-AVR.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
884
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
549
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.2K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
797
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.0K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
575